Skip to content

The study of BushenHuoxue Formula in clinical treatment evaluation for bone grafting after posterior lumbar interbody fusion.

The study of BushenHuoxue Formula in clinical treatment evaluation for bone grafting after posterior lumbar interbody fusion.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006667
Enrollment
Unknown
Registered
2022-09-29
Start date
2022-09-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal stenosis

Interventions

Control group:Bushenhuoxue Decoction granule simulation agent
Treatment group:Bushenhuoxue Decoction granules

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria of lumbar spinal stenosis or Lumbar disc herniation in western medicine, and already took posterior lumbar interbody fusion; 2. TCM syndrome differentiation after the operation is kidney deficiency and blood stasis; 3. Adult patients aged 20 to 75 years; 4. Patients who voluntarily participated in the clinical trial and signed the informed consent. Only those who meet the above four criteria can be selected as eligible subjects for this clinical study.

Exclusion criteria

Exclusion criteria: 1. Patients with lumbar tuberculosis, lumbar tumor, or lumbar compression fracture; 2. Postoperative complications such as infection and organ failure; 3. Patients with past adverse reactions to traditional Chinese Medicine. If any one of the above options is met, the case is excluded.

Design outcomes

Primary

MeasureTime frame
Brantigan Steffee Fraser evaluation criterion;Intervertebral height loss rate;Time required for intervertebral fusion;

Secondary

MeasureTime frame
Oswestry disability index;Pain visual analogue scales score;Traditional Chinese medicine syndrome integral;

Countries

China

Contacts

Public ContactYang Kexin

Wangjing Hospital, China Academy of Chinese Medical Sciences

13611261137@163.com+86 13611261137

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026